Published in Nicotine Tob Res on March 01, 2007
The Effect of Exercise on Acute Nicotine Withdrawal (NicEx) | NCT01047930
EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One (2013) 6.44
Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (2014) 5.33
Tobacco addiction. Lancet (2008) 3.65
Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) (2010) 2.44
Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29
Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci (2007) 2.11
Smoking and suicide: a brief overview. Drug Alcohol Depend (2008) 2.08
Resting state functional connectivity in addiction: Lessons learned and a road ahead. Neuroimage (2012) 2.02
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology (Berl) (2007) 1.92
Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr (2008) 1.88
Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci (2011) 1.83
DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction (2012) 1.81
The association between active smoking, smokeless tobacco, second-hand smoke exposure and insufficient sleep. Sleep Med (2010) 1.75
Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74
Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat (2008) 1.73
Suicidal behavior and depression in smoking cessation treatments. PLoS One (2011) 1.65
Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol Psychiatry (2013) 1.63
Subjective social status affects smoking abstinence during acute withdrawal through affective mediators. Addiction (2010) 1.60
Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60
Does progression through the stages of physical addiction indicate increasing overall addiction to tobacco? Psychopharmacology (Berl) (2011) 1.58
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend (2009) 1.53
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med (2012) 1.52
Managing smoking cessation. BMJ (2007) 1.48
A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend (2007) 1.47
Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers. Am J Addict (2012) 1.45
Effects of varenicline on smoking cue–triggered neural and craving responses. Arch Gen Psychiatry (2011) 1.45
Damage to the insula leads to decreased nicotine withdrawal during abstinence. Addiction (2015) 1.44
Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacology (Berl) (2007) 1.44
Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study. Addict Biol (2012) 1.36
Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol (2011) 1.33
A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome. Addict Behav (2010) 1.32
DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology (2008) 1.31
Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis (2010) 1.27
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. BMJ (2008) 1.23
Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology (2008) 1.20
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. J Gen Intern Med (2009) 1.19
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol (2011) 1.16
Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers. Psychopharmacology (Berl) (2013) 1.16
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev (2010) 1.15
Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res (2008) 1.14
The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect, and smoking behaviour: systematic review update and meta-analysis. Psychopharmacology (Berl) (2012) 1.13
The role of sleep hygiene in promoting public health: A review of empirical evidence. Sleep Med Rev (2014) 1.12
Depression moderates smoking behavior in response to a sad mood induction. Psychol Addict Behav (2009) 1.11
Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers. Biol Psychiatry (2013) 1.09
Adolescent brain maturation and smoking: what we know and where we're headed. Neurosci Biobehav Rev (2014) 1.06
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry (2012) 1.05
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy. Pharmacol Ther (2009) 1.04
Sex differences in negative affect and lapse behavior during acute tobacco abstinence: a laboratory study. Exp Clin Psychopharmacol (2013) 1.04
Nicotine withdrawal and agitation in ventilated critically ill patients. Crit Care (2010) 1.03
Varenicline in the treatment of tobacco dependence. Neuropsychiatr Dis Treat (2008) 1.03
ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework. Front Psychiatry (2014) 1.02
Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures. Addiction (2009) 1.01
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat (2008) 1.01
Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. J Abnorm Psychol (2012) 1.00
Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment. Front Psychiatry (2015) 0.99
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology (2013) 0.98
Mechanistic insights into nicotine withdrawal. Biochem Pharmacol (2011) 0.98
Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addict Behav (2010) 0.98
Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. Drug Alcohol Depend (2013) 0.98
Implementing smoking cessation guidelines for hospitalized veterans: effects on nurse attitudes and performance. J Gen Intern Med (2013) 0.97
Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addict Behav (2008) 0.97
Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment. Nicotine Tob Res (2010) 0.97
Dependence and withdrawal-induced craving predict abstinence in an incentive-based model of smoking relapse. Nicotine Tob Res (2012) 0.96
Markov model of smoking cessation. Proc Natl Acad Sci U S A (2011) 0.96
Nicotine withdrawal symptoms in adolescent and adult twins. Twin Res Hum Genet (2010) 0.94
The development and expression of physical nicotine dependence corresponds to structural and functional alterations in the anterior cingulate-precuneus pathway. Brain Behav (2014) 0.94
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning. Neurobiol Learn Mem (2013) 0.93
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. Exp Clin Psychopharmacol (2011) 0.93
Concurrent alcohol and tobacco treatment: Effect on daily process measures of alcohol relapse risk. J Consult Clin Psychol (2015) 0.91
Reduced executive and default network functional connectivity in cigarette smokers. Hum Brain Mapp (2014) 0.90
The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology (2012) 0.90
Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms. Psychopharmacology (Berl) (2013) 0.89
Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence? Addict Behav (2009) 0.89
Association of withdrawal features with nicotine dependence as measured by the Fagerström Test for Nicotine Dependence (FTND). Addict Behav (2008) 0.89
Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: a longitudinal perfusion fMRI study. Drug Alcohol Depend (2011) 0.89
Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol (2014) 0.89
Breaking the habit: a qualitative exploration of barriers and facilitators to smoking cessation in people with enduring mental health problems. BMC Public Health (2013) 0.89
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.89
The French Observational Cohort of Usual Smokers (FOCUS) cohort: French smokers perceptions and attitudes towards smoking cessation. BMC Public Health (2010) 0.89
Involvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal. Psychopharmacology (Berl) (2011) 0.88
Effects of instructions on responses to the nicotine patch: a laboratory study. Psychopharmacology (Berl) (2007) 0.88
Comparative dynamics of four smoking withdrawal symptom scales. Addiction (2012) 0.88
Urge to smoke over 52 weeks of abstinence. Psychopharmacology (Berl) (2012) 0.87
Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. Front Psychiatry (2013) 0.87
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J (2011) 0.87
Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. Cancer Epidemiol Biomarkers Prev (2009) 0.87
The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence. J Addict Med (2013) 0.87
Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline. Mayo Clin Proc (2009) 0.86
Joint analysis of stochastic processes with application to smoking patterns and insomnia. Stat Med (2013) 0.85
A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain. Neuropsychopharmacology (2012) 0.85
A randomized controlled trial of smartphone-based mindfulness training for smoking cessation: a study protocol. BMC Psychiatry (2015) 0.85
A randomized clinical trial of St. John's wort for smoking cessation. J Altern Complement Med (2010) 0.85
Thwarting science by protecting the received wisdom on tobacco addiction from the scientific method. Harm Reduct J (2010) 0.85
Smoking behaviour and mental health disorders--mutual influences and implications for therapy. Int J Environ Res Public Health (2013) 0.85
Posttraumatic stress symptoms and cigarette deprivation in the prediction of anxious responding among trauma-exposed smokers: a laboratory test. Nicotine Tob Res (2010) 0.83
Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal. Psychopharmacology (Berl) (2010) 0.83
Nicotine withdrawal and stress-induced changes in pain sensitivity: a cross-sectional investigation between abstinent smokers and nonsmokers. Psychophysiology (2014) 0.83
Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders. Addict Behav (2014) 0.83
Motivating and helping smokers to stop smoking. J Gen Intern Med (2003) 2.22
Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res (2007) 1.43
Depression during tobacco abstinence. Nicotine Tob Res (2007) 1.32
Ever users versus never users of a "less risky" cigarette. Psychol Addict Behav (2005) 0.89